HCP Live

Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

NeurologyLive® Staff

February 18th 2023

Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]

PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine

PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine

NeurologyLive® Staff

February 11th 2023

Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]

New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted

New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted

NeurologyLive® Staff

February 4th 2023

Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]

Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab

Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab

NeurologyLive® Staff

January 28th 2023

Neurology News Network for the week ending January 28, 2023. [WATCH TIME: 4 minutes]

COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA

COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA

NeurologyLive® Staff

January 21st 2023

Neurology News Network for the week ending January 21, 2022. [WATCH TIME: 3 minutes]

24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified

24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified

NeurologyLive® Staff

January 14th 2023

Neurology News Network for the week ending January 14, 2022. [WATCH TIME: 4 minutes]

FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold

FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold

NeurologyLive® Staff

December 31st 2022

Neurology News Network for the week ending December 31, 2022. [WATCH TIME: 3 minutes]

WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep

WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep

NeurologyLive® Staff

December 24th 2022

Neurology News Network for the week ending December 24, 2022. [WATCH TIME: 4 minutes]

Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence

Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence

NeurologyLive® Staff

December 17th 2022

Neurology News Network for the week ending December 17, 2022. [WATCH TIME: 4 minutes]

Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes

Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes

NeurologyLive® Staff

December 10th 2022

Neurology News Network for the week ending December 10, 2022. [WATCH TIME: 4 minutes]

Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs

Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs

NeurologyLive® Staff

December 3rd 2022

Neurology News Network for the week ending December 3, 2022. [WATCH TIME: 3 minutes]

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

NeurologyLive® Staff

November 26th 2022

Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

NeurologyLive® Staff

November 19th 2022

Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]

FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms

FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms

NeurologyLive® Staff

November 12th 2022

Neurology News Network for the week ending November 12, 2022. [WATCH TIME: 4 minutes]

Poor Sleep Associated With Cannabis and Alcohol Use, Dietary Approaches in MS, Noninvasive Brain Stimulation Effective in Alzheimer

Poor Sleep Associated With Cannabis and Alcohol Use, Dietary Approaches in MS, Noninvasive Brain Stimulation Effective in Alzheimer

NeurologyLive® Staff

November 5th 2022

Neurology News Network for the week ending November 5, 2022. [WATCH TIME: 3 minutes]

Apitegromab Improves Quality of Life in SMA, ARB Therapy Leads to Lowered Epilepsy Risk, Donanemab Reduces Alzheimer-Related Plasma Biomarkers

Apitegromab Improves Quality of Life in SMA, ARB Therapy Leads to Lowered Epilepsy Risk, Donanemab Reduces Alzheimer-Related Plasma Biomarkers

October 29th 2022

Neurology News Network for the week ending October 28, 2022. [WATCH TIME: 4 minutes]

Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen

Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen

NeurologyLive® Staff

October 22nd 2022

Neurology News Network for the week ending October 22, 2022. [WATCH TIME: 4 minutes]

Phase 3 LIGHTHOUSE Study Initiated, Trend Toward ASMs With Lower Teratogenic Risk, Rituximab Effects on NMOSD, MOGAD

Phase 3 LIGHTHOUSE Study Initiated, Trend Toward ASMs With Lower Teratogenic Risk, Rituximab Effects on NMOSD, MOGAD

NeurologyLive® Staff

October 15th 2022

Neurology News Network for the week ending October 15, 2022. [WATCH TIME: 3 minutes]

Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis

Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis

NeurologyLive® Staff

October 8th 2022

Neurology News Network for the week ending October 8, 2022. [WATCH TIME: 3 minutes]

Verdiperstat Fails ALS Study, Lecanemab Shines in Latest Phase 3 Findings, Ofatumumab Continues Superiority Over Teriflunomide

Verdiperstat Fails ALS Study, Lecanemab Shines in Latest Phase 3 Findings, Ofatumumab Continues Superiority Over Teriflunomide

NeurologyLive® Staff

October 1st 2022

Neurology News Network for the week ending October 1, 2022. [WATCH TIME: 4 minutes]

Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination

Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination

NeurologyLive® Staff

September 24th 2022

Neurology News Network for the week ending September 24, 2022. [WATCH TIME: 4 minutes]

Abnormal Vascular Hemodynamics Linked With Tau, Constant Therapy Shows Feasibility in Alzheimer Disease, LIFT-AD Study Amended

Abnormal Vascular Hemodynamics Linked With Tau, Constant Therapy Shows Feasibility in Alzheimer Disease, LIFT-AD Study Amended

NeurologyLive® Staff

September 17th 2022

Neurology News Network for the week ending September 17, 2022. [WATCH TIME: 4 minutes]

New Study on COVID-19 Vaccinations in MS, FDA Lifts Hold on SRP-5051, Implantable Loop Recorder and Atrial Fibrillation

New Study on COVID-19 Vaccinations in MS, FDA Lifts Hold on SRP-5051, Implantable Loop Recorder and Atrial Fibrillation

NeurologyLive® Staff

September 10th 2022

Neurology News Network for the week ending September 10, 2022. [WATCH TIME: 4 minutes]

FDA Approves Auotinjector for Status Epilepticus, Penumbra System Removes Clots in Ischemic Stroke, Tobacco Use Correlated With Cognitive Decline

FDA Approves Auotinjector for Status Epilepticus, Penumbra System Removes Clots in Ischemic Stroke, Tobacco Use Correlated With Cognitive Decline

NeurologyLive® Staff

September 3rd 2022

Neurology News Network for the week ending September 3, 2022. [WATCH TIME: 4 minutes]

Remote Ischemic Conditioning Improves Post Stroke Outcomes, Opiate Use High in Idiopathic Intracranial Hypertension, Drug Resistant Epilepsy and Increased Mortality

Remote Ischemic Conditioning Improves Post Stroke Outcomes, Opiate Use High in Idiopathic Intracranial Hypertension, Drug Resistant Epilepsy and Increased Mortality

NeurologyLive® Staff

August 27th 2022

Neurology News Network for the week ending August 27, 2022. [WATCH TIME: 4 minutes]

Results of VISIONARY-MS Study Released, Analysis Complete for Concussion Therapy OXE103, Chronic Kidney Disease Associated With Intracerebral Hemorrhage

Results of VISIONARY-MS Study Released, Analysis Complete for Concussion Therapy OXE103, Chronic Kidney Disease Associated With Intracerebral Hemorrhage

NeurologyLive® Staff

August 20th 2022

Neurology News Network for the week ending August 20, 2022. [WATCH TIME: 4 minutes]

Stigma Adds to Depressive Symptoms in Epilepsy, Parkinson Disease and Diabetes Show Increased Neuroaxonal Damage, ICER Publishes Report on ALS Treatments

Stigma Adds to Depressive Symptoms in Epilepsy, Parkinson Disease and Diabetes Show Increased Neuroaxonal Damage, ICER Publishes Report on ALS Treatments

NeurologyLive® Staff

August 13th 2022

Neurology News Network for the week of August 13, 2022. [WATCH TIME: 4 minutes]

Severe Preeclampsia Linked With Neuroinflammation, Neurofilament Light Associated With Memory Function, Discrimination Effects on Cognition

Severe Preeclampsia Linked With Neuroinflammation, Neurofilament Light Associated With Memory Function, Discrimination Effects on Cognition

NeurologyLive® Staff

August 6th 2022

Neurology News Network for the week ending August 6, 2022. [WATCH TIME: 4 minutes]

FDA Accepts NDA for Tofersen, Serious Falls Increased With Hypnotic Medications, Racial Disparities in Sleep of Pregnant Women

FDA Accepts NDA for Tofersen, Serious Falls Increased With Hypnotic Medications, Racial Disparities in Sleep of Pregnant Women

NeurologyLive® Staff

Neurology News Network for the week ending July 30, 2022. [WATCH TIME: 4 minutes]

CNM-Au8 Reduces Mortality in ALS, Prenatal Exposure to ASMs Increases Neurodevelopmental Disorders, FDA Grants Tentative Approval to FT218

CNM-Au8 Reduces Mortality in ALS, Prenatal Exposure to ASMs Increases Neurodevelopmental Disorders, FDA Grants Tentative Approval to FT218

NeurologyLive® Staff

Neurology News Network for the week ending July 23, 2022. [WATCH TIME: 4 minutes]

<1 2 3 4 5 6 7 8 >

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.